AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Channel opsins, proteins derived from algae, have the potential to revolutionize the treatment of psychiatric illnesses and nervous system disorders. These proteins can be introduced into the nervous systems of animals and humans, allowing for precise control of neuron activity in the brain and body using light. Unlike traditional drug treatments, channel opsins offer a more targeted approach, avoiding side effects and increasing treatment efficacy. They have shown promise in the treatment of depression, schizophrenia, epilepsy, and other conditions. Recent advancements have even enabled the restoration of vision in a blind patient using channel opsins. While further research is needed, this transformative technology has the potential to greatly impact the fields of psychiatry and mental health in the future.
Psychiatry faces the challenge of diagnosing and treating disorders that lack measurable biomarkers. The current reliance on words and symptom descriptions can be subjective and imprecise, leading to challenges in evaluating and treating patients. However, advances in optogenetics, such as the use of channel opsins, offer an opportunity to increase understanding by targeting specific circuits and cells in the brain. By studying the activity patterns of neurons and manipulating them with light, researchers can gain insights into the mechanisms underlying psychiatric disorders and develop more precise and effective treatments.
While there are various pharmaceutical and therapeutic interventions available for psychiatric disorders, their effectiveness can vary significantly among individuals. Many treatments come with unwanted side effects, and some patients do not respond to conventional approaches. The development of new interventions, such as optogenetics, holds promise for more targeted and personalized treatments. However, further research is needed to deepen our understanding of the neural circuits involved in psychiatric illnesses and to develop precise methodology for delivering light stimulation.
Optogenetics, particularly with the use of channel opsins, has the potential to revolutionize psychiatric treatments by allowing for precise stimulation of specific neuronal populations. By introducing channel opsins derived from algae into targeted brain regions, researchers can use light to control neuronal activity. This approach could potentially alleviate symptoms of depression, anxiety, and other psychiatric disorders more effectively and with fewer side effects. While challenges remain, such as achieving specificity and safe delivery of light, the potential benefits of optogenetics in psychiatry are truly exciting and warrant further exploration.
Psychodelic medicine, such as psychedelics like LSD and psilocybin, offer unique opportunities for the treatment of psychiatric conditions. They alter the experience of reality in precise ways, increasing the brain's willingness to accept unlikely hypotheses or construct new models of the world. These agents may help individuals with depression by increasing the flow of activity through brain circuitry and opening up new paths or representations of the future. While there are risks and challenges associated with these compounds, rigorous research and careful administration may lead to significant therapeutic benefits.
MDMA, commonly known as ecstasy, has shown promise in the treatment of trauma-related conditions. By simultaneously increasing the levels of dopamine and serotonin in the brain, MDMA can lead to improved emotional connectedness and a temporary reduction in fear or anxiety. The brain's response to MDMA may enhance learning and enable individuals to consider new possibilities and perspective. Further research and clinical trials are necessary to fully understand the mechanisms and potential benefits of MDMA in trauma treatment.
Dissociation, which involves a separation of self from the body, can occur in conditions like PTSD and borderline personality disorder. Optogenetics, a method involving the use of light to control neural activity, has allowed researchers to study dissociation in animal models and even in human patients with epilepsy. By manipulating specific circuits involved in dissociation, scientists have gained insights into the neural basis of this experience. Optogenetics offers a unique opportunity to understand and potentially develop targeted interventions for dissociative disorders.
In his book 'Projections: A Story of Human Emotions,' Dr. Karl Deisseroth shares a message of optimism for the future of psychiatry. He emphasizes the progress being made in understanding the brain and developing new treatments, while acknowledging the challenges that remain. Dr. Deisseroth envisions a future where advancements in technologies like optogenetics and psychopharmacology enable tailored treatments that provide relief to individuals suffering from psychiatric disorders. Although the path ahead is still complex, the trajectory of scientific discovery offers hope for a better understanding and treatment of mental health conditions.
Dr. Karl Deisseroth, MD, PhD, is a clinical psychiatrist and scientist who directs a bioengineering research laboratory at Stanford University School of Medicine. His work aims to understand and develop treatments for disorders of the mind such as depression, attention deficit disorders (ADHD & ADD), autism, schizophrenia, anxiety, eating disorders, borderline personality and obsessive-compulsive disorder. We discuss his experience treating his patients and his laboratory’s mission to find and develop cures for mental disease and tools for probing how the brain works.
Read the full show notes for this episode at hubermanlab.com.
AG1: https://athleticgreens.com/huberman
LMNT: https://drinklmnt.com/hubermanlab
Waking Up: https://wakingup.com/huberman
Momentous: https://livemomentous.com/huberman
00:00:00 Introduction
00:03:47 Sponsors: AG1, LMNT & Waking Up
00:07:41 Using Language to Understand the Mind
00:12:19 Blood Tests For Mental Disease
00:13:38 The Largest Challenges Facing Treatment of Mental Health
00:20:21 Predicting Depression & Suicide
00:22:47 Drugs That Work for Brain Illness
00:27:01 What Would A Cure For the Broken Mind Look Like?
00:32:23 Channelopsins: Tools For Understanding & Treating the Mind
00:39:10 Curing Blindness with Channelopsins
00:41:58 Why Karl Became a Scientist
00:47:10 Vagus Nerve In Depression
00:54:12 Challenges To Overcome for Treating Mental Illness with Channelopsins
00:58:34 Using the Dialogue with Patients to Guide Treatment
01:00:52 How Our Eyes Reveal Our Mental Health
01:06:04 Controlling Structures Deep In the Brain
01:08:23 The Most Effective Drugs Often Have the Most Side Effects
01:09:50 Do Psychiatrists Take the Drugs They Prescribe
01:14:15 Moving From Experimental Tools To Novel Treatments
01:16:00 Brain-Machine Interfaces & Neuralink
01:19:30 ADHD & Dr. Deisseroth’s Approach To Focusing His Mind
01:26:36 How Dr. Deisseroth Balances A Career In Medicine, Science & Family
01:35:41 New Ways of Exploring Brains: CLARITY
01:38:49 What Is Special About the Human Brain?
01:46:03 Psychedelics
01:54:12 MDMA
01:57:15 Dr. Deisseroth’s New Book “Projections: A Story of Emotions”
01:59:42 Connecting with Dr. Deisseroth on Twitter
Listen to all your favourite podcasts with AI-powered features
Listen to the best highlights from the podcasts you love and dive into the full episode
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
Listen to all your favourite podcasts with AI-powered features
Listen to the best highlights from the podcasts you love and dive into the full episode